secwatch.observer — SEC 8-K summary
======================================

Issuer:     Eloxx Pharmaceuticals, Inc. (ELOX)
CIK:        0001035354
Form:       8-K
Filed at:   2023-09-20T23:59:59+00:00
Accession:  0001104659-23-102293
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Eloxx Pharmaceuticals raises ~$2M in registered direct offering and private placement
--------------------------------------------------------------------------------

- Sold 305,590 shares + 75,000 pre-funded warrants at ~$5.255/unit, and 380,590 private warrants at $5.13 exercise.
- Gross proceeds approximately $2.0M; H.C. Wainwright placement agent with 7.5% fee and 22,835 warrant shares.
- Private and placement warrants issued unregistered under Section 4(a)(2) exemption.
- Pre-funded warrant exercise price $0.001; private warrant term 5.5 years; both have beneficial ownership caps.
- Proceeds intended for general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1035354/000110465923102293/0001104659-23-102293-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1035354/000110465923102293/tm2326470d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-102293

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer